Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 16
Phase 23
Phase 31

Trial Status

Completed7
Other3

Role Distribution

Principal Investigator10
PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT02242968Completed
Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products
Anti-Infective AgentsAntiviral AgentsImmunologic Factors+2 more
PrincipalinvestigatorStart date: 2023-04-24
NCT03719586Phase 2/3Completed
Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
Ebola Virus
PrincipalinvestigatorStart date: 2018-11-21
NCT02363322Phase 1/2Completed
Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
Ebola Virus Infection
PrincipalinvestigatorStart date: 2015-03-13
NCT02338986Completed
Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Communicable DiseasesCommunicable Diseases, EmergingEmerging Infectious Diseases+1 more
PrincipalinvestigatorStart date: 2015-03-04
NCT00646152Phase 1Completed
Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study
EbolaInfluenzaSevere Acute Respiratory Distress Syndrome+2 more
Principalinvestigator
NCT01441024Phase 2Withdrawn
DAS181 in Patients With Parainfluenza
Parainfluenza Infection
Principalinvestigator
NCT01747148Phase 1Completed
Testing the AVI-7100 Flu Drug in Healthy Volunteers
Influenza
Principalinvestigator
NCT02788188Phase 1Completed
Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Middle East Respiratory Syndrome Coronavirus
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT02242968PrincipalInvestigator

Screening of Volunteers for Clinical Trials of Investigational or Licensed Vaccines or Antiviral Products

Anti-Infective AgentsAntiviral AgentsImmunologic Factors+2 more
Completed
NCT03719586Phase 2/3PrincipalInvestigator

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Ebola Virus
Completed
NCT02363322Phase 1/2PrincipalInvestigator

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Ebola Virus Infection
Completed
NCT02338986PrincipalInvestigator

Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases

Communicable DiseasesCommunicable Diseases, EmergingEmerging Infectious Diseases+1 more
Completed
NCT00646152Phase 1PrincipalInvestigator

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

EbolaInfluenzaSevere Acute Respiratory Distress Syndrome+2 more
Completed
NCT01441024Phase 2PrincipalInvestigator

DAS181 in Patients With Parainfluenza

Parainfluenza Infection
Withdrawn
NCT01747148Phase 1PrincipalInvestigator

Testing the AVI-7100 Flu Drug in Healthy Volunteers

Influenza
Completed
NCT02037282Phase 1PrincipalInvestigator

A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects

FluInfluenza
Withdrawn
NCT02389192Phase 1PrincipalInvestigator

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Healthy
Withdrawn
NCT02788188Phase 1PrincipalInvestigator

Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults

Middle East Respiratory Syndrome Coronavirus
Completed

All 10 trials loaded